It's important to remember that any weight management journey requires time and determination
The eligibility requirements for filing a gastroparesis claim consist of: Documented use of Ozempic, Wegovy, Rybelsus, Mounjaro, or other GLP-1 receptor agonists with prescription records or pharmacy documentation Gastroparesis diagnosis or related gastrointestinal condition (ileus, intestinal obstruction, gastric outlet obstruction) from a healthcare provider Symptoms occurring during drug use or within 30-60 days of discontinuation Medical intervention demonstrating injury severity: emergency room visits, hospitalization for at least 24 hours, or gastroenterologist consultation Persistent symptoms lasting four weeks or longer, particularly cyclic vomiting episodes No prior history of gastroparesis, gastric surgery (bypass, banding, sleeve), or conditions causing similar symptoms Medical records documenting treatment attempts and ongoing symptom management Cases filed within applicable statute of limitations (typically 1-3 years from injury discovery) The ongoing legal debate regarding diagnostic testing requirements impacts case eligibility determinations
While a patient can stop semaglutide, it has been generally touted as a long-term treatment option for chronic disease management
Severe symptoms are less common over time
Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes
